BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06789913-completion@plaintrial.com
DTSTAMP:20261027T171302Z
DTSTART;VALUE=DATE:203110
SUMMARY:A Phase 2 Study of Mutant-selective PI3Kα Inhibitor\, RLY-2608\, i
 n Adults and Children With PIK3CA Related Overgrowth Spectrum and Malforma
 tions Driven by PIK3CA Mutation — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06789913
URL:https://plaintrial.com/trial/NCT06789913
END:VEVENT
END:VCALENDAR